Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction: Long-term results of the REVIVAL-2 trial

Thrombosis and Haemostasis

Volumn 115, Issue 4, 2016, Pages 864-868

  Steppich, Birgit ^a   Hadamitzky, Martin ^a   Ibrahim, Tareq ^b   Groha, Philip ^a   Schunkert, Heribert ^a   Laugwitz, Karl Ludwig ^b   Kastrati, Adnan ^a   Ott, Ilka ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute myocardial infarction; Cardiology; Clinical studies; Granulocyte colony stimulating factor; Stem cells

Indexed keywords

FILGRASTIM; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL MOBILIZATION; SUDDEN CARDIAC DEATH; TUBERCULOSIS; VERY ELDERLY; BIOLOGICAL THERAPY; CONTROLLED STUDY; MORTALITY; MYOCARDIAL INFARCTION; TIME FACTOR; TREATMENT OUTCOME;

AGED; BIOLOGICAL THERAPY; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84964442192     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-07-0589     Document Type: Article

References (24)

1. Zohlnhöfer D, Ott I, Mehilli J, et al. Stem cell mobilisation by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. J Am Med Assoc 2006; 295: 1003–1010.
2. San Roman JA, Sánchez PL, Villa A et al. Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI: A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial. J Am Coll Cardiol 2015; 65: 2372–2382.
3. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving func- tion and survival. Proc Natl Acad Sci USA 2001; 98: 10344–10349.
4. Kajstura J, Rota M, Whang B, et al. Bone marrow cells differentiate in cardiac cell lineages after infarc- tion independently of cell fusion. Circ Res 2005; 96: 127–137.
5. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005; 85: 1373–1416.
6. Minatoguchi S, Takemura G, Chen XH, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004; 109: 2572–2580.
7. Ohki Y, Heissig B, Sato Y, et al. Granulocyte colony- stimulating factor promotes neovascularisation by re- leasing vascular endothelial growth factor from neutrophils. FASEB J 2005; 19: 2005–2007.
8. Sugano Y, Anzai T, Yoshikawa T, et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 2005; 65: 446–456.
9. Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012; 2: CD006536.
10. Moazzami K, Roohi A, Moazzami B. Granulocyte colony stimulating factor therapy for acute myocardial infarction. Cochrane Database Syst Rev 2013; 5: CD008844.
11. Baldo MP, Davel AP, Nicoletti-Carvalho JE, et al. Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats. J Cardiovasc Pharmacol 2008; 52: 375–380.
12. Ripa RS, Jørgensen E, Kastrup J. Clinical outcome after stem cell mobilisation with granulocyte-colony-stimulating factor after acute ST-elevation myocardial infarction: 5-year results of the STEMMI trial. Scand J Clin Lab Invest 2013; 73: 125–129.
13. Ripa RS, Jørgensen E, Wang Y, et al. Stem cell mobilisation induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled Stem cells in Myocardial Infarction(STEMMI)trial. Circulation 2006; 113: 1983–1992.
14. Achilli F, Malafronte C, Maggiolini S, et al. G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial. Heart 2014; 100: 574–581.
15. Sato D, Otani H, Fujita M, et al. Granulocyte colony-stimulating factor does not enhance recruitment of bone marrow-derived cells in rats with acute myocardial infarction. Exp Clin Cardiol 2012; 17: 83–88.
16. Taghavi S, George JC Homing of stem cells to ischaemic myocardium. Am J Transl Res 2013; 5: 404–411.
17. Shah VK, Shalia KK. Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora’s Box. Stem Cells Int 2011; 2011: 536758.
18. Zaruba MM, Franz WM. Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischaemic cardiomyopathy. Expert Opin Biol Ther 2010; 10: 321–335.
19. Vagima Y, Lapid K, Kollet O, et al. Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis. Methods Mol Biol 2011; 750: 277–289.
20. Stein A, Zohlnhöfer D, Pogatsa-Murray G, et al. Expression of CXCR4, VLA-1, LFA-3 and transducer of ERB in G-CSF-mobilised progenitor cells in acute myocardial infarction. Thromb Haemost 2010; 103: 638–643.
21. Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204–1219.
22. Steppich BA, Demetz G, Schulz S, et al. Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction. Thromb Res 2011; 127: 119–121.
23. Kang S, Yang Y, Li C, et al. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Clinical Therapeutics 2007; 29: 2406–2418.
24. Steinwender C, Hofmann R, Kypta A, et al. Late stent thrombosis after transcoronary transplantation of granulocyte-colony stimulating factor-mobilized peripheral blood stem cells following primary percutaneous intervention for acute myocardial infarction. Int J Cardiol 2007; 122: 248–249.